Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2024

02.10.2023 | General Gynecology

Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?

verfasst von: Omer Moore, Tamar Tzur, Zvi Vaknin, Moran Landau Rabbi, Noam Smorgick

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

To describe the feasibility of hysteroscopy-assisted suction curettage for early pregnancy loss and to investigate whether it reduces the rates of retained products of conception (RPOC) and intrauterine adhesions (IUA).

Design

Prospective single-arm cohort study.

Setting

University-affiliated Department of Obstetrics and Gynecology.

Patients

Women admitted for surgical evacuation of early pregnancy loss were invited to participate in the study.

Intervention

Vaginal misoprostol was administered for cervical ripening preoperatively. Under general anesthesia, a diagnostic hysteroscopy was performed to identify the pregnancy’s implantation wall, followed by ultrasound-guided suction and curettage directed to the implantation wall, and then diagnostic hysteroscopy to verify complete uterine cavity emptying. Postoperative IUA were evaluated by follow-up office hysteroscopy.

Main Outcome Measure

Identification of the pregnancy’s implantation wall on hysteroscopy, and intra-, and postoperative complications associated with the procedure. The evaluation of postoperative IUA was limited due to the COVID-19 pandemic-related restrictions on elective procedures.

Results

Forty patients were included in the study group. Their mean age was 34.0 ± 6.6 years, and their mean gestational age was 8.9 ± 1.6 weeks. The implantation wall was clearly visualized on hysteroscopy in 33 out of 40 cases (82.5%). The mean operative time was 17.2 ± 8.8 min, and no intraoperative complications occurred. Suspected RPOC were diagnosed intraoperatively by hysteroscopy and removed in 4 cases, and the histologic examination confirmed the presence of RPOC in three of them. Follow-up office hysteroscopy was performed in nine women: mild IUA was diagnosed in one case and a normal cavity was confirmed in eight cases. A new pregnancy was reported at the time of follow-up in 15 cases, while 12 women declined to attend the follow-up hysteroscopy and four were lost to follow-up.

Conclusions

Hysteroscopy-assisted suction curettage for early pregnancy loss is a safe, short, and inexpensive procedure, which allows the identification of the pregnancy’s wall in most cases and may reduce the rates of RPOC.
Literatur
1.
Zurück zum Zitat Hooker AB, Lemmers M, Thurkow AL, Heymans MW, Opmeer BC, Brölmann HA, Mol BW, Huirne JA (2014) Systematic review and meta-analysis of intrauterine adhesions after miscarriage: Prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 20:262–278CrossRefPubMed Hooker AB, Lemmers M, Thurkow AL, Heymans MW, Opmeer BC, Brölmann HA, Mol BW, Huirne JA (2014) Systematic review and meta-analysis of intrauterine adhesions after miscarriage: Prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 20:262–278CrossRefPubMed
2.
Zurück zum Zitat Jones RK, Kooistra K (2011) Abortion incidence and access to services in the United States, 2008. Perspect Sex Reprod Health 43:41–50CrossRefPubMed Jones RK, Kooistra K (2011) Abortion incidence and access to services in the United States, 2008. Perspect Sex Reprod Health 43:41–50CrossRefPubMed
3.
Zurück zum Zitat Wieringa-de Waard M, Vos J, Bonsel GJ, Bindels PJ, Ankum WM (2002) Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation. Hum Reprod 17:2445–2450CrossRefPubMed Wieringa-de Waard M, Vos J, Bonsel GJ, Bindels PJ, Ankum WM (2002) Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation. Hum Reprod 17:2445–2450CrossRefPubMed
4.
Zurück zum Zitat Dempsey A, Davis A (2008) Medical management of early pregnancy failure: how to treat and what to expect. Semin Reprod Med 26:401–410CrossRefPubMed Dempsey A, Davis A (2008) Medical management of early pregnancy failure: how to treat and what to expect. Semin Reprod Med 26:401–410CrossRefPubMed
5.
Zurück zum Zitat Hooker A, Fraenk D, Brölmann H, Huirne J (2016) Prevalence of intrauterine adhesions after termination of pregnancy: a systematic review. Eur J Contracept Reprod Health Care 21:329–335CrossRefPubMed Hooker A, Fraenk D, Brölmann H, Huirne J (2016) Prevalence of intrauterine adhesions after termination of pregnancy: a systematic review. Eur J Contracept Reprod Health Care 21:329–335CrossRefPubMed
6.
Zurück zum Zitat Smorgick N, Levinsohn-Tavor O, Ben-Ami I, Maymon R, Pansky M, Vaknin Z (2017) Hysteroscopic removal of retained products of conception following first trimester medical abortion. Gynecol Minim Invasive Ther 6:183–185CrossRefPubMedPubMedCentral Smorgick N, Levinsohn-Tavor O, Ben-Ami I, Maymon R, Pansky M, Vaknin Z (2017) Hysteroscopic removal of retained products of conception following first trimester medical abortion. Gynecol Minim Invasive Ther 6:183–185CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Westendorp IC, Ankum WM, Mol BW, Vonk J (1998) Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod 13:3347–3350CrossRefPubMed Westendorp IC, Ankum WM, Mol BW, Vonk J (1998) Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod 13:3347–3350CrossRefPubMed
8.
Zurück zum Zitat Vitale SG, Parry JP, Carugno J, Cholkeri-Singh A, Della Corte L, Cianci S, Schiattarella A, Riemma G, De Franciscis P (2021) Surgical and reproductive outcomes after hysteroscopic removal of retained products of conception: a systematic review and meta-analysis. J Minim Invasive Gynecol 28:204–217CrossRefPubMed Vitale SG, Parry JP, Carugno J, Cholkeri-Singh A, Della Corte L, Cianci S, Schiattarella A, Riemma G, De Franciscis P (2021) Surgical and reproductive outcomes after hysteroscopic removal of retained products of conception: a systematic review and meta-analysis. J Minim Invasive Gynecol 28:204–217CrossRefPubMed
9.
Zurück zum Zitat Foreste V, Gallo A, Manzi A, Riccardi C, Carugno J, Sardo ADS (2021) Hysteroscopy and retained products of conception: an update. Gynecol Minim Invasive Ther 10:203–209CrossRefPubMedPubMedCentral Foreste V, Gallo A, Manzi A, Riccardi C, Carugno J, Sardo ADS (2021) Hysteroscopy and retained products of conception: an update. Gynecol Minim Invasive Ther 10:203–209CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat The American Fertility Society (1988) Classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril 49:944–955CrossRef The American Fertility Society (1988) Classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril 49:944–955CrossRef
11.
Zurück zum Zitat AAGL Elevating Gynecologic Surgery (2017) AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). Gynecol Surg 14:6CrossRefPubMedCentral AAGL Elevating Gynecologic Surgery (2017) AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). Gynecol Surg 14:6CrossRefPubMedCentral
12.
Zurück zum Zitat Debby A, Malinger G, Harow E, Golan A, Glezerman M (2006) Transvaginal ultrasound after first-trimester uterine evacuation reduces the incidence of retained products of conception. Ultrasound Obstet Gynecol 27:61–64CrossRefPubMed Debby A, Malinger G, Harow E, Golan A, Glezerman M (2006) Transvaginal ultrasound after first-trimester uterine evacuation reduces the incidence of retained products of conception. Ultrasound Obstet Gynecol 27:61–64CrossRefPubMed
13.
Zurück zum Zitat Chaikof M, Lazer T, Gat I, Quach K, Alkudmani B, Zohni K, Baratz A, Glass K, Sharma P, Librach C (2017) Lower complication rates with office-based D&C under ultrasound guidance for missed abortion. Minerva Ginecol 69:23–28PubMed Chaikof M, Lazer T, Gat I, Quach K, Alkudmani B, Zohni K, Baratz A, Glass K, Sharma P, Librach C (2017) Lower complication rates with office-based D&C under ultrasound guidance for missed abortion. Minerva Ginecol 69:23–28PubMed
15.
Zurück zum Zitat de Codt M, Balza C, Jadoul P, Forget P, Squifflet JL, Bernard P, Luyckx M (2020) Hysteroscopic resection for missed abortion: feasibility, operative technique and potential benefit compared to curettage. Front Surg 8(7):64CrossRef de Codt M, Balza C, Jadoul P, Forget P, Squifflet JL, Bernard P, Luyckx M (2020) Hysteroscopic resection for missed abortion: feasibility, operative technique and potential benefit compared to curettage. Front Surg 8(7):64CrossRef
16.
Zurück zum Zitat Weinberg S, Pansky M, Burshtein I, Beller U, Goldstein H, Barel O (2021) A pilot study of guided conservative hysteroscopic evacuation of early miscarriage. J Minim Invasive Gynecol 28:1860–1867CrossRefPubMed Weinberg S, Pansky M, Burshtein I, Beller U, Goldstein H, Barel O (2021) A pilot study of guided conservative hysteroscopic evacuation of early miscarriage. J Minim Invasive Gynecol 28:1860–1867CrossRefPubMed
17.
Zurück zum Zitat Vitale SG, Riemma G, Carugno J, Perez-Medina T, Alonso Pacheco L, Haimovich S, Parry JP, Di Spiezio SA, De Franciscis P (2022) Postsurgical barrier strategies to avoid the recurrence of intrauterine adhesion formation after hysteroscopic adhesiolysis: a network meta-analysis of randomized controlled trials. Am J Obstet Gynecol 226:487-498.e8CrossRefPubMed Vitale SG, Riemma G, Carugno J, Perez-Medina T, Alonso Pacheco L, Haimovich S, Parry JP, Di Spiezio SA, De Franciscis P (2022) Postsurgical barrier strategies to avoid the recurrence of intrauterine adhesion formation after hysteroscopic adhesiolysis: a network meta-analysis of randomized controlled trials. Am J Obstet Gynecol 226:487-498.e8CrossRefPubMed
18.
Zurück zum Zitat Korany S, Baradwan S, Badghish E, Talat Miski N, Alshahrani MS, Khadawardi K, Baradwan A, Alanwar A, Labib K, Dahi AA, Hamed WM, Abdallah KM, Badawy MA, Kamel M, Abbas AM, Ahmaro M, Abdelhakim AM, Sileem SA (2022) Value of intrauterine platelet-rich concentrates in patients with intrauterine adhesions after hysteroscopy: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 271:63–70CrossRefPubMed Korany S, Baradwan S, Badghish E, Talat Miski N, Alshahrani MS, Khadawardi K, Baradwan A, Alanwar A, Labib K, Dahi AA, Hamed WM, Abdallah KM, Badawy MA, Kamel M, Abbas AM, Ahmaro M, Abdelhakim AM, Sileem SA (2022) Value of intrauterine platelet-rich concentrates in patients with intrauterine adhesions after hysteroscopy: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 271:63–70CrossRefPubMed
19.
Zurück zum Zitat Hooker AB, de Leeuw RA, van de Ven PM, Brölmann HAM, Huirne JAF (2018) Reproductive performance after the application of hyaluronic acid gel after dilation and curettage in women who have experienced at least one previous curettage: long-term results of a multicenter prospective randomized trial. Fertil Steril 110:1231–1238CrossRefPubMed Hooker AB, de Leeuw RA, van de Ven PM, Brölmann HAM, Huirne JAF (2018) Reproductive performance after the application of hyaluronic acid gel after dilation and curettage in women who have experienced at least one previous curettage: long-term results of a multicenter prospective randomized trial. Fertil Steril 110:1231–1238CrossRefPubMed
20.
Zurück zum Zitat Hajšek P, Riemma G, Korošec S, Laganà AS, Chiantera V, Mikuš M, Ban Frangež H (2022) Does hysteroscopic dissection of partial uterine septum represent a risk factor for placental abnormalities in subsequent pregnancy compared with controls undergoing other hysteroscopic surgery? results from a large case-control analysis. J Clin Med 12:177CrossRefPubMedPubMedCentral Hajšek P, Riemma G, Korošec S, Laganà AS, Chiantera V, Mikuš M, Ban Frangež H (2022) Does hysteroscopic dissection of partial uterine septum represent a risk factor for placental abnormalities in subsequent pregnancy compared with controls undergoing other hysteroscopic surgery? results from a large case-control analysis. J Clin Med 12:177CrossRefPubMedPubMedCentral
Metadaten
Titel
Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?
verfasst von
Omer Moore
Tamar Tzur
Zvi Vaknin
Moran Landau Rabbi
Noam Smorgick
Publikationsdatum
02.10.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2024
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-023-07238-8

Weitere Artikel der Ausgabe 1/2024

Archives of Gynecology and Obstetrics 1/2024 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.